Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. AVDL.NASDAQ

Avadel Pharmaceuticals PLC (AVDL NASDAQ) stock market data APIs

$16.53 -0.19(-1.1%) as of July 26, 2024
Price chart is built with Anychart

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Avadel Pharmaceuticals PLC Financial Data Overview

16.72
16.53
-
16.815
16.34
9.5-19.09
1 587 M
96 202 K
55 141 K
1.632
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'AVDL',
Type: 'Common Stock',
Name: 'Avadel Pharmaceuticals PLC',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00FPFX9W4',
ISIN: NULL,
CUSIP: NULL,
CIK: '1012477',
EmployerIdNumber: '98-1341933',
FiscalYearEnd: 'December',
IPODate: '1996-06-07',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
HomeCategory: 'ADR',
IsDelisted: false,
}

Avadel Pharmaceuticals PLC Fundamental Data is available in our Financial Data APIs

  • Net Revenue 55 141 K
  • EBITDA -133 867 000
  • Earnings Per Share -1.82
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Avadel Pharmaceuticals PLC Earnings via APIs

  • Latest Release 2024-07-31
  • EPS/Forecast NaN

Get Avadel Pharmaceuticals PLC End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Avadel Pharmaceuticals PLC latest news via APIs

Avadel Pharmaceuticals to Join Russell 3000® Index

Avadel Pharmaceuticals plc DUBLIN, June 27, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, annou...

Harrow (HROW) Soars 12.9%: Is Further Upside Left in the Stock?

Harrow HROW shares soared 12.9% in the last trading session to close at $19.93. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the s...
Do you have any questions?
support@eodhistoricaldata.com